By Counterforce Health Team in Gilenya (fingolimod) —

How to Get Gilenya (Fingolimod) Covered by Aetna CVS Health in North Carolina: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Gilenya (Fingolimod) Covered by Aetna CVS Health in North Carolina

Aetna requires prior authorization for Gilenya (fingolimod) with approval valid for 12 months. Your neurologist must submit documentation including MS diagnosis (ICD-10 G35), baseline EKG, ophthalmology exam, vaccination records, and prior therapy history. Submit requests at least 2 weeks before treatment start through Availity portal or fax to 1-866-249-6155. If denied, North Carolina residents have strong appeal rights through Smart NC's external review program. First step today: Call the member services number on your Aetna card to verify Gilenya's formulary status and your specific requirements.

Table of Contents

  1. Coding Basics: Medical vs. Pharmacy Benefit Paths
  2. ICD-10 Mapping for Multiple Sclerosis
  3. Product Coding: NDC Numbers and Billing
  4. Clean Prior Authorization Request Anatomy
  5. Frequent Pitfalls and How to Avoid Them
  6. Verification Steps with Aetna CVS Health
  7. Appeals Playbook for North Carolina
  8. Quick Audit Checklist
  9. FAQ

Coding Basics: Medical vs. Pharmacy Benefit Paths

Gilenya (fingolimod) is an oral multiple sclerosis medication that typically falls under your pharmacy benefit, not medical benefit. This means it's processed through CVS Caremark (Aetna's pharmacy benefit manager) rather than through medical claims.

Key differences:

  • Pharmacy benefit: Uses NDC codes, requires specialty pharmacy dispensing, subject to formulary tiers and prior authorization
  • Medical benefit: Uses HCPCS/J-codes for injectable/infusible drugs administered in clinical settings

Since Gilenya is self-administered at home, it doesn't have a dedicated HCPCS J-code and must be billed using valid NDC numbers through specialty pharmacy channels.

ICD-10 Mapping for Multiple Sclerosis

The correct ICD-10 code for relapsing-remitting multiple sclerosis is G35.A, which falls under the broader G35 classification. Your neurologist's documentation must clearly specify:

MS Type ICD-10 Code Documentation Requirements
Relapsing-remitting MS G35.A Clear episodes with recovery periods
Secondary progressive MS G35.C Previous relapsing course, now progressive
Primary progressive MS G35.B Progressive from onset
Unspecified MS G35.D When specific type unclear

Documentation words that support coding:

  • "Relapsing-remitting multiple sclerosis"
  • "Clinical relapses followed by recovery"
  • "MRI evidence of disease activity"
  • "Gadolinium-enhancing lesions"
  • "New T2 lesions"

Product Coding: NDC Numbers and Billing

Gilenya does not have a dedicated HCPCS J-code since it's an oral medication. Instead, billing requires valid NDC (National Drug Code) numbers:

  • Brand Gilenya 0.5mg: Multiple NDCs depending on package size
  • Brand Gilenya 0.25mg: For pediatric patients (≤40kg)
  • Generic fingolimod: Various NDCs from different manufacturers

Dosing requirements:

  • Adults and children >40kg: 0.5mg daily
  • Children 10+ years and ≤40kg: 0.25mg daily

Units and billing: Since Gilenya is typically dispensed as a 30-day supply, the quantity will reflect 30 capsules for most prescriptions.

Clean Prior Authorization Request Anatomy

A complete Aetna prior authorization request for Gilenya must include:

Required Clinical Documentation

1. Diagnosis Confirmation

  • ICD-10 code G35.A (or appropriate subtype)
  • Neurologist's clinical notes confirming relapsing forms of MS
  • Recent MRI showing disease activity or documented clinical relapses

2. Baseline Testing (within 30-90 days)

  • EKG results: Required due to bradycardia risk
  • Comprehensive ophthalmology exam: With dilated fundus examination to screen for macular edema
  • Laboratory tests: CBC with differential, liver function tests
  • VZV immunity: Testing or vaccination records

3. Prior Therapy History

  • Names and dates of all previous disease-modifying therapies
  • Specific reasons for discontinuation (treatment failures or intolerance)
  • Documentation of inadequate response or adverse effects

Submission Methods

Submit through one of these channels:

  • Availity portal (Novologix module for specialty drugs) - preferred method
  • Fax: 1-866-249-6155 (specialty requests)
  • Mail: Medical Exception to Pharmacy Prior Authorization Unit, 1300 East Campbell Road, Richardson, TX 75081
Note: Gilenya must be filled through CVS Specialty Pharmacy, not local retail pharmacies.

Frequent Pitfalls and How to Avoid Them

Common Denial Reasons and Solutions

Denial Reason How to Fix
Missing baseline EKG Submit EKG results and 6-hour monitoring plan
Incomplete ophthalmology exam Provide full report with macular assessment
Missing vaccination records Document VZV status or contraindication
Step therapy not documented Include therapy history with outcomes and MRI results
Insufficient MS diagnosis Add neurologist notes, MRI findings, and ICD-10 G35 code

Documentation Mistakes to Avoid

  • Outdated testing: Baseline tests older than 90 days
  • Missing prescriber credentials: Must be board-certified neurologist
  • Incomplete prior therapy records: Vague reasons for discontinuation
  • Wrong ICD-10 code: Using G35 instead of specific subtype

Verification Steps with Aetna CVS Health

Before submitting your prior authorization:

1. Verify Coverage

  • Call member services (number on your insurance card)
  • Confirm Gilenya's formulary tier and coverage status
  • Ask about step therapy requirements for your specific plan

2. Check Requirements

  • Review your plan's prior authorization criteria
  • Confirm required baseline testing timeframes
  • Verify submission methods and contact information

3. Specialty Pharmacy Setup

  • Ensure prescription will be processed through CVS Specialty
  • Confirm your contact information for coordination

Appeals Playbook for North Carolina

If your Gilenya prior authorization is denied, North Carolina offers strong consumer protections through multiple appeal levels.

Internal Appeals with Aetna

Level 1: Standard Internal Appeal

  • Timeline: File within 60 calendar days of denial
  • Decision time: 30-45 days (expedited: 72 hours if urgent)
  • How to file: Online, phone (1-855-463-0933), fax, or mail
  • Required: Prescriber's medical necessity statement

External Review Through Smart NC

North Carolina residents have access to independent external review for denials based on medical necessity or experimental/investigational determinations.

Eligibility Requirements:

  • Must have exhausted internal appeals (or qualify for expedited review)
  • Member cost-sharing exceeds $500
  • Denial based on medical necessity or experimental status
  • State-regulated plan (not self-funded employer plans unless opted in)

How to Request External Review:

  1. Download form: NC State Health Plan Member Complaint and Appeal Form
  2. Gather documents: Denial letters, clinical records, prescriber support
  3. Submit within: 120 days of final internal denial
  4. Decision timeline: 45 days (expedited: 72 hours)
Tip: Smart NC staff can help you complete the external review request. Call their helpline at 1-855-408-1212 for free advocacy support.

Smart NC Contact Information:

When External Review Decisions Are Binding

If Smart NC's Independent Review Organization (IRO) overturns the denial, Aetna must provide coverage within 3 business days. The decision is binding on the insurer.

Counterforce Health specializes in turning insurance denials into targeted, evidence-backed appeals. The platform helps patients, clinicians, and specialty pharmacies by ingesting denial letters, plan policies, and clinical notes to identify the denial basis and draft point-by-point rebuttals aligned to the plan's own rules.

Quick Audit Checklist

Before submitting your Gilenya prior authorization:

Clinical Documentation:

  • ICD-10 code G35.A (or appropriate MS subtype)
  • Board-certified neurologist prescription
  • Recent MRI or clinical relapse documentation
  • Complete prior therapy history with outcomes

Baseline Testing (within 30-90 days):

  • EKG results and monitoring plan
  • Ophthalmology exam with macular assessment
  • CBC with differential
  • Liver function tests
  • VZV immunity documentation

Submission Details:

  • Submitted at least 2 weeks before treatment start
  • Correct fax number or portal used
  • All required forms completed
  • CVS Specialty Pharmacy confirmed as dispensing location

FAQ

How long does Aetna prior authorization take in North Carolina? Standard decisions typically take 30-45 days. Expedited requests (when health is jeopardized) are decided within 72 hours.

What if Gilenya is non-formulary on my plan? You can request a formulary exception with documentation showing medical necessity and that formulary alternatives are inappropriate or ineffective.

Can I request an expedited appeal? Yes, if a delay would seriously jeopardize your life or ability to regain function. Your doctor's support strengthens an expedited request.

Does step therapy apply if I've tried MS drugs outside North Carolina? Yes, prior therapy history from other states counts. Provide complete documentation of previous treatments, durations, and outcomes.

What happens if I miss the appeal deadline? Contact Smart NC immediately. In some cases, good cause exceptions may apply, especially if you weren't properly notified of your appeal rights.

How much does Gilenya cost with Aetna coverage? Costs vary by plan. Brand Gilenya can exceed $10,000/month without coverage, but generics are significantly less expensive. Check your specific copay and deductible.

Can I use manufacturer copay assistance with Aetna? Many Aetna plans allow manufacturer copay cards, but some exclude them. Verify with member services and check Novartis's patient assistance programs.

What if my neurologist isn't board-certified? Aetna typically requires board-certified neurologists to prescribe Gilenya. If your current prescriber doesn't meet this requirement, you may need a referral to a qualified specialist.

For complex denials or appeals, Counterforce Health's platform can help identify specific denial reasons and generate evidence-backed appeals that address payer requirements point-by-point.

Sources & Further Reading

Disclaimer: This guide provides general information about insurance coverage and appeals processes. It is not medical advice. Always consult with your healthcare provider about treatment decisions and work with qualified professionals for insurance appeals. Coverage policies and requirements may change; verify current information with your insurer and state regulators.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.